References
- Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303–27. Epub 2008/06/28.10.1086/591413
- Kimberlin DW. Ganciclovir may be used during intravenous aciclovir shortage [database on the Internet]. 2009. Available from: http://aapnews.aappublications.org/content/early/2009/02/10/aapnews.20090210-1.1.full?rss=1
- Wang Y, Smith KP. Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection. J Pediatr Pharmacol Ther. 2014;19(2):72–82. Epub 2014/07/16.10.5863/1551-6776-19.2.72
- Hirabayashi K, Nakazawa Y, Katsuyama Y, Yanagisawa T, Saito S, Yoshikawa K, et al. Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid. Infection. 2013;41(1):219–23. Epub 2012/09/14.10.1007/s15010-012-0329-3
- Chavanet P, Malet J, Waldner A, Aho S, Buisson M, Bielefeld P, et al. A double-blind randomized placebo trial on very high doses of acyclovir in weakly symptomatic HIV-patients. Cancer Detect Prev. 1990;14(6):669–73. Epub 1990/01/01.